Theramex, a London, UK-based specialty pharma company focusing on women's health, is changing hands in a deal reportedly ...
Businesses are finding that AI is a great leveller. Organisations with mature digital infrastructures can use AI to unlock ...
As an oncologist with more than 25 years of experience across clinical care, research, drug and device development, and ...
Novo has raised its financial guidance for 2026 on the back of rising sales of its oral weight-loss therapy Wegovy, which ...
The BioInnovation Institute (BII) has expanded a network striving to develop treatments for cardiometabolic diseases and ...
Hard on the heels of a £1 billion investment package by pharma companies in last week's UK Budget, AbbVie has pledged another ...
Boehringer Ingelheim is paying $358 million upfront to claim options on up to six antibody-drug conjugates (ADCs) and T cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results